Should I or shouldn’t I: perspectives regarding the decision-making process on stem cell treatments

To further public understanding of regenerative medicine, EuroStemCell has published lay summaries for all articles from the latest Regenerative Medicine special focus issue.

Go to the profile of Regenerative Medicine
Dec 11, 2017

EuroStemCell have launched a digital platform to accompany the publication of the Regenerative Medicine two-part Special Focus Issue entitled “Regenerative Medicine in Society: Interdisciplinary Perspectives”. The platform presents lay summaries of each article in the issue which are freely available to all in order to engage and educate non-experts on the key issues surrounding regenerative medicine.

You can now read the lay summary for the article entitled '‘No one here's helping me, what do you do?’: addressing patient need for support and advice about stem cell treatments' from Claire Tanner, Alan Petersen & Megan Munsie [1].

Deciphering available information, from both online and other sources, can be difficult for individuals trying to decide whether or not to travel and pay for possible stem cell treatments. Often these individuals seek out advice and guidance from others they perceive to be more knowledgeable on stem cell treatments to help them make their decisions. Interviews conducted by Dr. Claire Tanner and colleagues reveal many of the challenges and frustrations patients, carers and professionals - acting as advisors – experience. They also highlight the need to create better resources and call for one-on-one discussions to better support those contemplating alleged stem cell therapies that are yet to be shown to be safe and effective.  

What questions & challenges are raised? What insight and direction does this give for research policies? To find out, read the full lay summary on the EuroStemCell website here:

The full original article can be accessed here:


[1] Tanner C, Petersen A, Munsie M‘No-one here's helping me, what do you do?’: addressing patient need for support and advice about stem cell treatmentsRegen. Med. 12(7), 791–801 (2017).

Go to the profile of Regenerative Medicine

Regenerative Medicine

Journal, Future Science Group

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Emcare, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Journal Citation Reports/Science Edition®, Scopus® with an Impact Factor of 2.786 (2014). Each issue contains expertly drafted Reviews, Original Research articles, Perspectives, Editorials, topical insight from international leaders in their field, and additional added-value content. The Senior Editor of the journal is Professor Chris Mason, University College London. You can find out more about Regenerative Medicine at our website (, where you can find the aims and scope of the journal and details of our international editorial board.

No comments yet.